These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37667500)

  • 1. Synergy between amikacin and Protium heptaphyllum essential oil against polymyxin resistance Klebsiella pneumoniae.
    de Melo ALF; Rossato L; Veloso TC; Cardoso CAL; Velasques J; Simionatto S
    J Appl Microbiol; 2023 Sep; 134(9):. PubMed ID: 37667500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin combined with
    de Melo ALF; Rossato L; Velasques J; de Sousa VL; Pina Rodrigues GV; Cardoso CAL; Arantes JP; Lima BF; Simionatto S
    J Med Microbiol; 2024 Sep; 73(9):. PubMed ID: 39292222
    [No Abstract]   [Full Text] [Related]  

  • 3. An approach to combat multidrug-resistant K. pneumoniae strain using synergistic effects of Ocotea diospyrifolia essential oil in combination with amikacin.
    Pimentel Arantes J; Dillis Faccin I; Coutinho EJ; Lima Cardoso CA; Lopes Fernandes SS; Rossato L; Simionatto E; Simionatto S
    Microb Pathog; 2024 Aug; 193():106782. PubMed ID: 38969186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
    Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling synergism of polymyxin B with chloramphenicol derivatives against multidrug-resistant (MDR) Klebsiella pneumoniae.
    Idris N; Leong KH; Wong EH; Abdul Rahim N
    J Antibiot (Tokyo); 2023 Dec; 76(12):711-719. PubMed ID: 37821539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin Resistance in Clinical Isolates of
    Conceição-Neto OC; da Costa BS; Pontes LDS; Silveira MC; Justo-da-Silva LH; de Oliveira Santos IC; Teixeira CBT; Tavares E Oliveira TR; Hermes FS; Galvão TC; Antunes LCM; Rocha-de-Souza CM; Carvalho-Assef APD
    Front Cell Infect Microbiol; 2022; 12():898125. PubMed ID: 35909953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates co-harbouring aminoglycoside-modifying enzymes, bla
    Firmo EF; Oliveira Júnior JB; Scavuzzi AML; Alves LC; Brayner FA; Veras DL; Lopes ACS
    J Glob Antimicrob Resist; 2020 Sep; 22():511-514. PubMed ID: 32344124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.
    Elemam A; Rahimian J; Doymaz M
    J Clin Microbiol; 2010 Oct; 48(10):3558-62. PubMed ID: 20686085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant
    Loho T; Sukartini N; Astrawinata DAW; Immanuel S; Aulia D; Priatni I
    Can J Infect Dis Med Microbiol; 2018; 2018():1047670. PubMed ID: 30065794
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Goel A; Gupta V; Singhal L; Palta S; Chander J
    Indian J Med Res; 2021 Mar; 154(3):520-526. PubMed ID: 35345078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
    Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii.
    Knezevic P; Aleksic V; Simin N; Svircev E; Petrovic A; Mimica-Dukic N
    J Ethnopharmacol; 2016 Feb; 178():125-36. PubMed ID: 26671210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
    Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
    J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
    Borjan J; Meyer KA; Shields RK; Wenzler E
    Int J Antimicrob Agents; 2020 Jan; 55(1):105852. PubMed ID: 31770627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing
    Erturk Sengel B; Altinkanat Gelmez G; Soyletir G; Korten V
    J Chemother; 2020 Sep; 32(5):237-243. PubMed ID: 32228228
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens.
    Vasconcelos NG; Queiroz JHFS; Silva KED; Vasconcelos PCP; Croda J; Simionatto S
    PLoS One; 2020; 15(7):e0236505. PubMed ID: 32701970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary Study on the Antibacterial Activity of Essential Oils Alone and in Combination with Gentamicin Against Extended-Spectrum β-Lactamase-Producing and New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae Isolates.
    Kwiatkowski P; Pruss A; Grygorcewicz B; Wojciuk B; Dołęgowska B; Giedrys-Kalemba S; Kochan E; Sienkiewicz M
    Microb Drug Resist; 2018 Nov; 24(9):1368-1375. PubMed ID: 29708847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City.
    Manning N; Balabanian G; Rose M; Landman D; Quale J
    Microb Drug Resist; 2018; 24(1):35-39. PubMed ID: 28590820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China.
    Chen X; Li P; Sun Z; Xu X; Jiang J; Su J
    J Glob Antimicrob Resist; 2022 Sep; 30():357-362. PubMed ID: 35817263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Amaral SC; Pruski BB; de Freitas SB; Allend SO; Ferreira MRA; Moreira C; Pereira DIB; Junior ASV; Hartwig DD
    Mol Biol Rep; 2020 Dec; 47(12):9615-9625. PubMed ID: 33190200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.